Schedule 13G ownership disclosure
PHASEBIO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 717224109
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,869,650
- Percent of class
- 5.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001678858-22-000330
- Form type
- SC 13G
- Filer
- PhaseBio Pharmaceuticals Inc
- CIK
- CIK 1169245
- Filed
- Feb 04, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership